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The endoplasmic reticulum (ER) is responsible for folding and delivery of secretory proteins to their
site of action. One major modiﬁcation proteins undergo in this organelle is N-glycosylation. Proteins
that cannot fold properly will be directed to a process known as endoplasmic reticulum associated
degradation (ERAD). Processing of N-glycans generates a signal for ERAD. The lectin Yos9 recognizes
the N-glycan signal of misfolded proteins and acts as a gatekeeper for the delivery of these sub-
strates to the cytoplasm for degradation. Presence of Yos9 accelerates degradation of the glycosyl-
ated model ERAD substrate CPY⁄. Here we show that Yos9 has also a control function in
degradation of the unglycosylated ERAD substrate CPY⁄0000. It decelerates its degradation rate.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction the glycan tree linked to the protein. Subsequently the lectinThe endoplasmic reticulum (ER) is the entry site of proteins into
the secretory pathway of eukaryotic cells. More than one quarter of
the eukaryotic proteome passes the ER membrane and folds to
their native conformation in this compartment. Over 5% of the
cell’s proteome is responsible for a functional ER (Saccharomyces
Genome Database). During folding these secretory proteins can un-
dergo three kinds of modiﬁcations: glycosylation, disulﬁde bond
formation and speciﬁc proteolytic cleavage [1]. An optimal chaper-
one equipment in the ER assists folding of the heavy protein load
[2]. Properly folded proteins are ﬁnally sorted to their different
sites of action, which include the lysosome (vacuole), the plasma
membrane and the exterior of the cell [1].
However, due to statistic errors, mutations, heat, heavy metals
or oxidative stress folding errors occur resulting in misfolded pro-
teins that impair cellular protein homeostasis [2–4]. Therefore the
ER must detect permanently misfolded proteins, prevent them
from secretion and deliver them to the endoplasmic reticulum
associated degradation (ERAD) machinery for degradation. Upon
import into the ER most nascent proteins are N-glycosylated with
a Glc3Man9GlcNAc2 carbohydrate chain [5,6]. During protein fold-
ing the three glucose residues are removed. In Saccharomyces cere-
visiae if a protein is not properly folded by then, the slow-acting
mannosidase I (Mns1) cleaves a mannose from the B branch ofchemical Societies. Published by E
.H. Wolf).Mnl1/Htm1, which has mannosidase activity, cleaves an additional
mannose residue from the C branch yielding a Man7GlcNAc2 struc-
ture with an exposed a1,6 linkage [7–10]. If the misfolded protein
has a lesion located in the ER lumen it is recruited to the Hrd/Der
ligase complex via binding to Hrd3 [11]. The lectin Yos9, an inte-
gral subunit of the Hrd/Der ligase complex, recognizes the a1,6
linked mannose of the Man7GlcNAc chain of the glycosylated pro-
teins via its MRH domain and targets them to the ERAD machinery
[7,8,12–14]. Substrates are retro-translocated across the ER mem-
brane, polyubiquitylated by the E3 enzyme Der3/Hrd1, extracted
from the membrane by the AAA-ATPase machinery Cdc48-Ufd1-
Npl4, and delivered to the proteasome via the ubiquitin receptors
Dsk2 and Rad23 for degradation [15–19].
Major attention has been given to the degradation of misfolded
glycosylated proteins of the ER [9,10,20,21]. As the ER processes
non-glycosylated proteins, which might also undergo misfolding,
here we investigated their fate in ERAD. For this purpose, we chose
a non-glycosylated version of misfolded carboxypeptidase Y
(CPY⁄0000) [20].
2. Materials and methods
2.1. Yeast strains and plasmids
Molecular biological and genetic techniques were carried out
using standard methods [22]. S. cerevisiae strains used in this study
are based on YWO0636 (MATa, ade2-1, can1-100, his3-11 15, leu2-3,lsevier B.V. All rights reserved.
Table 1
Strains used in this study.
Strain Genotype Source
YWO0340 W303 MATalpha, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::hisG, pep4D::HIS3, prb1D::hisG K. Kuchler
YWO0361 WCG MATa, his3-11 15, leu2-3 112, ura3, prc1-1 Knop et al. 1996 [30]
YWO0364 WCG MATa, his3-11 15, leu2-3 112, ura3, prc1-1, pre1-1, pre4-1 Hilt et al. 1993 [28]
YWO0636 W303 MATalpha, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2 Plemper et al. 1999 [41]
YWO0820 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc D::LEU2, mnl/htm1D::kanMX6 Kostova et al. 2005 [20]
YWO1154 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D ::LEU2, yos9D::HIS3MX6 Buschhorn et al. 2004 [12]
YWO1268 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, usa1D::kanMX6 H. Hoshida
YWO1408 W303 MATalpha, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, der3D::HIS3 A. Schäfer
YWO1526 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, doa10D::kanMX6 This study
YWO1643 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, der1D::His5+ S. Besser
YWO1792 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, der1D, yos9D::HIS3MX6 A. Becher
YWO1793 W303 MATa, ade2-1, can1-100, his3-11 15, leu2-3 112, trp1-1, ura3-1, prc1D::LEU2, usa1D, yos9D::HIS3MX6 A. Becher
Table 2
Plasmids used in this study.
Plasmid Characteristics Backbone Source
PWO0604 CPY⁄0000, PRC1 promoter and terminator pRS316 Kostova et al. 2005 [20]
PWO0612 CPY⁄, PRC1 promoter and terminator pRS316 Buschhorn et al.2004 [12]
pUG27 Deltion vector Güldener et al. 1996 [23]
PWO1114 Yos9R200A-Flag pRS314 O. Fischer
3016 E. Martinez Benitez et al. / FEBS Letters 585 (2011) 3015–3019112, trp1-1, ura3-1, prc1D::LEU2) and YWO0361 (WCG MATa, his3-
11 15, leu2-3 112, ura3, prc1-1), Strains YWO1792 and YWO1973
were generated from strains YWO1643 and YWO1268 respec-
tively, according to Güldener et al. after pop out of the auxotrophic
markers and using plasmid pFA6a-His3MX6 and primers EMB021
and EMB022 for the deletion of the YOS9 gene [23]. Construction
of the glycosylation mutant CPY⁄0000 was described previously
[20]. Tables 1–3 list the yeast strains, plasmids and primers used.
2.2. Pulse-chase analysis and immunoprecipitation
Cells were grown at 30 C to logarithmic phase in 20 ml of selec-
tive media. For each strain 40 ODs of cells were taken. They were
washed 5 times with 1 ml starvation media (0.67% (w/v) yeast
nitrogen base w/o amino acids, 2% glucose, 0.012% (w/v) L-alanine,
L-isoleucine, L-leucine, L-arginine, L-lysine, L-aspartate, L-cysteine,
L-phenylalanine, L-glutamate, L-threonine, L-glutamine, L-trypto-
phan, L-glycine, L-valine, L-proline, L-histidine, L-serine, L-tyrosine,
L-asparagine, myo-inositol, p-aminobenzoic acid, pH 5.6) and
resuspended in 1 ml starvation media in 50 ml tubes. Cells under-
went starvation for 50 min at 30 C. Then 20 ll of methionine la-
beled with the radioactive isotope 35S (10 lCi/ll) was added and
cultures were incubated 20 min under the same conditions. During
this time all newly synthesized proteins integrate radioactive
methionine into their sequence. After these 20 min, 1 ml of chase
media (starvation media plus 0.2% BSA, 0.6% non-labeled L-methi-
onine) was added and samples (450 ll) were collected at different
time points (see ﬁgures) in microtubes containing 500 ll of 20 mM
NaN3. Samples were kept on ice or stored at 20 C. The tubes with
thawed cells were centrifuged for 15 min at 13000 rpm and the
supernatant was discarded. The pellet was resuspended in 100 ll
of BB1 buffer (50 mM Tris/HCl pH 7.5, 6 M urea, 1 mM EDTA, 1%
(w/v) SDS) and 67 ll of glass beads added. Samples were vortexedTable 3
Primers.
EMB021 agatcttcacatatatcgttatcatcccctttcttccctgtttcacagctgaagcttcgtacgc
EMB022 gcaaaacgtgaaaaaaaaaaattaaaagtttatactcctccttgtgcataggccactagtggatctg5 times for 1 min with a minute interruption on ice. Then, cell ex-
tracts were resuspended in 1 ml IP buffer (50 mM Tris/HCl pH 7.5,
190 mM NaCl 1.25% TritonX-100 (v/v), 6 mM EDTA) and spun
down for 15 min at 14000 rpm. Next, 900 ll of the supernatant
was transferred to a microtube containing 3 ll of polyclonal CPY
antibody (Rockland) for immunoprecipitation. Immunoprecipita-
tion took place during 90 min at room temperature, followed by
the addition of 80 ll of 7% Protein A sepharose suspension (GE
healthcare). During 90 min incubation the antibodies bind to the
sepharose. After 5 washings with IP buffer (2000 rpm) all non-
bound proteins to the antibody and sepharose are eliminated. In
the ﬁnal centrifugation step the IP buffer is removed completely
and 60 ll SDS loading buffer are added. Samples are subjected to
SDS–PAGE (7.5% polyacrylamide gel) and thereafter the gel is dried
at 60 C on a Whatman paper with the aid of a vacuum. Whatman
papers containing the sample gels are ﬁxed in a cassette and ex-
posed to a phosphor screen. The screen is analyzed using a Phos-
phoImager scanner and ImageQuaNT™ software. In each time
point of the experiments the mean ± interval of conﬁdence with
an a = 0.05 for the error bars is calculated.
3. Results and discussion
It had been shown that the four N-carbohydrates on CPY⁄ are
not equal in their capability to act as signals for ERAD. The most
C-terminal of the four glycans in CPY⁄ is required and sufﬁcient
to trigger efﬁcient degradation. However, the unglycosylated ver-
sion of CPY⁄ (CPY⁄0000) is still degraded but at a considerably re-
duced rate [20].
We wanted to elucidate the degradation mechanism of this
misfolded unglycosylated CPY⁄ protein. To rule out autophagy we
checked the degradation proﬁle of CPY⁄0000 by pulse-chase exper-
iments in cells with defective vacuolar function. The vacuole is
equipped with two major endopeptidases, proteinase yscA (gene
PEP4/PRA1) an aspartyl protease, and proteinase yscB (gene
PRB1), a serine protease. When both proteinases are absent the
proteolytic vacuolar function is severely compromised [24,25].
When testing CPY⁄0000 degradation in Dpep4Dprb1 double mu-
tants the same CPY⁄0000 degradation proﬁle was visible as in wild
Fig. 1. The vacuole is not required for CPY⁄0000 degradation. Cells with defective
vacuolar function (Dpep4/pra1Dprb1) were transformed with a CPY⁄0000 expres-
sion plasmid. The pulse-chase data represent the means of four independent
experiments and interval of conﬁdence with an a = 0.05 for the error bars is
calculated.
Fig. 2. CPY⁄0000 is an ERAD-L substrate. (A) Cells with defective proteasomes
(pre1-1, pre4-1) were transformed with a CPY⁄0000 expression plasmid. (B) DER3/
HRD1 deleted cells were transformed with a CPY⁄0000 expression plasmid showing
a stabilization of the substrate. The pulse-chase data represent the means of 3 (wild
type and proteasome mutant) to four (wild type and Dder3/hrd1) independent
experiments and interval of conﬁdence with an a = 0.05 for the error bars is
calculated.
Fig. 3. Degradation efﬁciency of CPY⁄0000 in DER1 and USA1 deleted cells. All
indicated strains were transformed with a CPY⁄0000 expression plasmid. (A)
CPY⁄0000 degradation in wild type,Dder1 and Dusa1 strains was followed by pulse-
chase experiments. (B) CPY⁄0000 degradation in Dyos9 (control), Dder1Dyos9 and
Dusa1Dyos9 strains. The pulse-chase data represent the means of two (Dder1Dyos9
and Dusa1Dyos9), four (wild type and Dusa1) and seven (Dder1 strain and Dyos9
control) independent experiments and interval of conﬁdence with an a = 0.05 for
the error bars is calculated.
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degradation (Fig. 1).
To conﬁrm whether CPY⁄0000 is a bona ﬁde ERAD substrate we
tested the involvement of the main components of the ubiquitin
proteasome system (UPS) in its elimination. We followed CPY⁄0000
degradation in cells expressing defective proteasomes, as well as
cells deleted in different E3 ubiquitin ligases [26–28]. When testing
degradation of CPY⁄0000 in mutants with defects in the Pre1 and
the Pre4 subunits of the proteasome a considerable stabilization
of the misfolded protein as compared to wild type cells was appar-
ent (Fig. 2A). Thus, the proteasome is the proteolytic machinery for
CPY⁄0000 elimination. Ubiquitylation of glycosylated CPY⁄, a prere-
quisite for degradation, is carried out by the E3 ligase Der3/Hrd1.
We therefore tested if this enzyme was involved in elimination
of non-glycosylated CPY⁄0000. As can be seen in Fig. 2B degrada-
tion of the misfolded non-glycosylated enzyme is indeed slowed
down in Dder3/Dhrd1 mutant cells, indicating its requirement for
the elimination process. The second E3 ligase of the ER, Doa10
[29] was also tested, with no effect in CPY⁄0000 turnover (data
not shown). Clearly, CPY⁄0000 is an ERAD-L substrate.
We therefore tested if also the ER membrane protein Der1, re-
quired for elimination of soluble ERAD-L substrates and Usa1,
which links Der1 to the Der3/Hrd1 ligase, are part of the degrada-
tion process [30–35]. Fig. 3A shows that deletion of any of theseproteins leads to a similar, but rather marginal reduction in the
degradation kinetics of CPY⁄0000.
Even though at ﬁrst glance we did not expect any effect on the
degradation of non-glycosylated CPY⁄0000 in mutants carrying
deletions in the lectin-like proteins Mnl1/Htm1 and Yos9 which
interact with the glycan residues of glycosylated CPY⁄
[7,12,14,36], we nevertheless tested the degradation behavior of
CPY⁄0000 in such mutant strains. As expected, deletion of
MNL1/HTM1 did not lead to any alteration of the degradation kinet-
ics of CPY⁄0000 (Fig. 4A). Unexpectedly, deletion of the YOS9 gene
led to a considerably enhanced elimination kinetics of CPY⁄0000
(Fig. 4B). Obviously, Yos9 does not only play a role in recognition
in the ERAD of glycosylated substrates, but also of non-glycosyl-
ated substrates. While Yos9 promotes degradation of glycosylated
substrates (Supplementary Fig. 1) [12,14], it seems to have an
opposite function in degradation of non-glycosylated CPY⁄0000
by slowing down its degradation. The ﬁnding that absence of
Yos9 accelerates degradation of CPY⁄0000 led us to repeat the
experiments on the inﬂuence of the ERAD-L components Der1
and Usa1 in a YOS9 deletion strain. The degradation kinetics of
CPY⁄0000 is considerably reduced in DER1 and USA1 deleted strains
when Yos9 is absent (Fig. 3B). This clearly shows the need of Der1
and Usa1 for degradation of non-glycosylated CPY⁄0000.
We tested if the mannose-6-phosphate receptor homology do-
main (MRH) of Yos9, which is responsible for recognition of glycos-
ylated substrates, is recognizing non-glycosylated CPY⁄0000
[37,38]. This is not the case: The degradation kinetics of CPY⁄0000
is similar in wild type and in Yos9 mutant cells bearing a mutation
in the MRH domain (R200A), which abrogates its lectin function
(Fig. 4B). An interaction between the MRH domain mutated Yos9
protein and CPY⁄0000 had previously been shown [14]. This corre-
lates with our data and suggests a checkpoint function of Yos9 for
unglycosylated substrates.
This work shows that the non-glycosylated substrate CPY⁄0000
is a bona ﬁde ERAD-L substrate. Recently, this has also been shown
Fig. 4. The degradation efﬁciency of CPY⁄0000 in MNL1/HTM1 deleted cells, YOS9
deleted cells and cells expressing Yos9 carrying a mutation in the MRH domain. (A)
MNL1/HTM1 deleted cells were transformed with a CPY⁄0000 expression plasmid.
Pulse-chase analyses were performed. (B) Wild type and Dyos9 trains were
transformed with CPY⁄0000 or CPY⁄0000 and Yos9R200A-Flag expression plasmids
respectively and pulse-chase analyses were performed. Data represent the means of
four (wild type and Dmnl1/htm1), six (Yos9R200A) and seven (Dyos9) independent
experiments and interval of conﬁdence with an a = 0.05 for the error bars is
calculated.
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yscA [39,40]. Efﬁcient degradation of CPY⁄0000 depends on the
Hrd/Der complex. While the presence of the lectin Yos9 in the
complex promotes degradation of glycosylated misfolded proteins,
we could show here that it hinders degradation of unglycosylated
CPY⁄0000. Degradation kinetics of CPY⁄0000 is not affected by the
R200A mutation in the MRH domain of Yos9 which abrogates its
lectin function, conﬁrming a second function for this ERAD compo-
nent. We hypothesize that Yos9 has a checkpoint function for non-
glycosylated misfolded proteins. This could be part of a timer for
unglycosylated substrates: Yos9 may bind any misfolded protein
via a hydrophobic patch and after checking the glycan structure
by the MRH domain, it delivers the glycosylated misfolded proteins
to the ubiquitin-proteasome system, while non-glycosylated pro-
teins remain bound until they are properly folded or, when unsuc-
cessful, are slowly delivered to the degradation machinery.
Without doubt, Yos9 plays a tuning role in ERAD, independent of
the glycosylation state of the substrate.
4. Note added in proof
While this paper was under review the following paper has
been published: Yos9p assists in the degradation of certain non-
glycosylated proteins from the endoplasmic reticulum. Jaenicke L
A, Brendebach H, Selbach M and Hirsch C. (2011) Mol Biol Cell.
Jul 7. Epub ahead of print.
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